Brand Institute Receives EMA Approval for AI-Developed Pharmaceutical Brand Name Using Brandi Platform
Brand Institute announced that the European Medicines Agency (EMA) has approved a pharmaceutical brand name developed using its AI-powered naming platform, Brandi™. This marks the first time an AI-assisted naming process from the company has received regulatory approval from a major global health authority. The milestone highlights growing acceptance of AI tools in pharmaceutical branding while reinforcing that human expertise and regulatory oversight remain central to the final naming process. 
Brand Institute Receives EMA Approval for AI-Developed Pharmaceutical Brand Name Using Brandi Platform